How much funding has RQ Bio raised?

RQ Bio has raised $115.0M in total funding, most recently a venture unknown round.

Where is RQ Bio headquartered?

RQ Bio is headquartered in London, United States.

What industry is RQ Bio in?

RQ Bio operates in Biotech, Healthcare.

RQ Bio

London, United States · $115.0M raised

Biotech

Healthcare

Headquarters: London
Employees: 11–50
Business Model: B2B
Website: rqbio.com

Total Funding: $115.0M
Last Round: $115.0M Venture RoundJun 2026
Rounds: 1

About

RQ Bio (RQ Biotechnology Ltd.) is a London-based clinical-stage biotechnology company focused on developing preventative antibody-based medicines for infectious diseases. Its lead program RQB01 is a long-acting, broad-spectrum antibody therapeutic designed to provide season-long protection against seasonal influenza in high-risk patient populations, currently in preclinical development.

Summary

RQ Bio is a Biotech company based in London, United States. It has raised $115.0M in total across 1 round, most recently a $115.0M Venture Round round in Jun 2026.